Ph.D., former Head of Medicinal Chemistry at Roche UK, and Vice-president Chemistry and Preclinical Sciences within Roche Bioscience, Palo Alto, USA. Geoff is the co-inventor of Cilazapril ®, a marketed drug. He has extensive experience in drug discovery and provides advice to a number of small companies. He was the founding Research Director with Lectus Therapeutics. He is a founder of INMedD, a new medicine discovery social enterprise. He also serves on the Scientific Advisory Board of Peakdale Molecular and advised Prolysis, a british antibacterial company recently acquired by the Australian company Biota.